239 related articles for article (PubMed ID: 29229426)
1. CBX4 exhibits oncogenic activities in breast cancer via Notch1 signaling.
Zeng JS; Zhang ZD; Pei L; Bai ZZ; Yang Y; Yang H; Tian QH
Int J Biochem Cell Biol; 2018 Feb; 95():1-8. PubMed ID: 29229426
[TBL] [Abstract][Full Text] [Related]
2. Circular RNA hsa_circ_0008039 promotes proliferation, migration and invasion of breast cancer cells through upregulating CBX4 via sponging miR-515-5p.
Huang FJ; Dang JQ; Zhang S; Cheng ZY
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1887-1898. PubMed ID: 32141558
[TBL] [Abstract][Full Text] [Related]
3. miR-129-5p suppresses breast cancer proliferation by targeting CBX4.
Meng R; Fang J; Yu Y; Hou LK; Chi JR; Chen AX; Zhao Y; Cao XC
Neoplasma; 2018; 65(4):572-578. PubMed ID: 29940764
[TBL] [Abstract][Full Text] [Related]
4. Targeting the CK1α/CBX4 axis for metastasis in osteosarcoma.
Wang X; Qin G; Liang X; Wang W; Wang Z; Liao D; Zhong L; Zhang R; Zeng YX; Wu Y; Kang T
Nat Commun; 2020 Feb; 11(1):1141. PubMed ID: 32111827
[TBL] [Abstract][Full Text] [Related]
5. CBX4 Suppresses Metastasis via Recruitment of HDAC3 to the Runx2 Promoter in Colorectal Carcinoma.
Wang X; Li L; Wu Y; Zhang R; Zhang M; Liao D; Wang G; Qin G; Xu RH; Kang T
Cancer Res; 2016 Dec; 76(24):7277-7289. PubMed ID: 27864346
[TBL] [Abstract][Full Text] [Related]
6. CBX4 promotes the proliferation and metastasis via regulating BMI-1 in lung cancer.
Hu C; Zhang Q; Tang Q; Zhou H; Liu W; Huang J; Liu Y; Wang Q; Zhang J; Zhou M; Sheng F; Lai W; Tian J; Li G; Zhang R
J Cell Mol Med; 2020 Jan; 24(1):618-631. PubMed ID: 31724308
[TBL] [Abstract][Full Text] [Related]
7. Chromobox 4 facilitates tumorigenesis of lung adenocarcinoma through the Wnt/β-catenin pathway.
Wang Z; Fang Z; Chen G; Liu B; Xu J; Li F; Li F; Liu H; Zhang H; Sun Y; Tian G; Chen H; Xu G; Zhang L; Hu L; Ji H
Neoplasia; 2021 Feb; 23(2):222-233. PubMed ID: 33387960
[TBL] [Abstract][Full Text] [Related]
8. Long intergenic noncoding RNA00265 promotes proliferation of gastric cancer via the microRNA-144-3p/Chromobox 4 axis.
Yang Z; OuYang X; Zheng L; Dai L; Luo W
Bioengineered; 2021 Dec; 12(1):1012-1025. PubMed ID: 33464142
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-6838-5p suppresses the self-renewal and metastasis of human liver cancer stem cells through downregulating CBX4 expression and inactivating ERK signaling.
Dou Z; Lu F; Hu J; Wang H; Li B; Li X
Biol Chem; 2023 Jan; 404(1):29-39. PubMed ID: 36215729
[TBL] [Abstract][Full Text] [Related]
10. CBX4 transcriptionally suppresses KLF6 via interaction with HDAC1 to exert oncogenic activities in clear cell renal cell carcinoma.
Jiang N; Niu G; Pan YH; Pan W; Zhang MF; Zhang CZ; Shen H
EBioMedicine; 2020 Mar; 53():102692. PubMed ID: 32113161
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
[TBL] [Abstract][Full Text] [Related]
12. MiRNA-101 inhibits breast cancer growth and metastasis by targeting CX chemokine receptor 7.
Li JT; Jia LT; Liu NN; Zhu XS; Liu QQ; Wang XL; Yu F; Liu YL; Yang AG; Gao CF
Oncotarget; 2015 Oct; 6(31):30818-30. PubMed ID: 26360780
[TBL] [Abstract][Full Text] [Related]
13. SUMO E3 ligase CBX4 regulates hTERT-mediated transcription of CDH1 and promotes breast cancer cell migration and invasion.
Sanyal S; Mondal P; Sen S; Sengupta Bandyopadhyay S; Das C
Biochem J; 2020 Oct; 477(19):3803-3818. PubMed ID: 32926159
[TBL] [Abstract][Full Text] [Related]
14. Chromobox homolog 4 is correlated with prognosis and tumor cell growth in hepatocellular carcinoma.
Wang B; Tang J; Liao D; Wang G; Zhang M; Sang Y; Cao J; Wu Y; Zhang R; Li S; Ding W; Zhang G; Kang T
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S684-92. PubMed ID: 23943028
[TBL] [Abstract][Full Text] [Related]
15. MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel.
Zhang HD; Sun DW; Mao L; Zhang J; Jiang LH; Li J; Wu Y; Ji H; Chen W; Wang J; Ma R; Cao HX; Wu JZ; Tang JH
Biochem Biophys Res Commun; 2015 Oct; 465(4):702-13. PubMed ID: 26299922
[TBL] [Abstract][Full Text] [Related]
16. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.
Lei R; Tang J; Zhuang X; Deng R; Li G; Yu J; Liang Y; Xiao J; Wang HY; Yang Q; Hu G
Oncogene; 2014 Mar; 33(10):1287-96. PubMed ID: 23474751
[TBL] [Abstract][Full Text] [Related]
17. miR-30a inhibits the biological function of breast cancer cells by targeting Notch1.
Zhang HD; Jiang LH; Sun DW; Li J; Tang JH
Int J Mol Med; 2017 Oct; 40(4):1235-1242. PubMed ID: 28765900
[TBL] [Abstract][Full Text] [Related]
18. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
19. Targeting of miR9/NOTCH1 interaction reduces metastatic behavior in triple-negative breast cancer.
Mohammadi-Yeganeh S; Mansouri A; Paryan M
Chem Biol Drug Des; 2015 Nov; 86(5):1185-91. PubMed ID: 25963903
[TBL] [Abstract][Full Text] [Related]
20. [Notch signaling in human breast cancer].
Dong XB; Ji CY; Ma DX; Ma R; Zang SL; Yu HQ; Guo DM
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):425-8. PubMed ID: 17974275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
